4
Changes in Ownership
C4 Therapeutics, Inc. Filed Acc 0001209191-21-055886
Director sold 9,210 shares at an average $50.05 ($460,985)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Prokupets Elena Director | 2021-09-10 | Sale | −1,230 | $50.00 | $61,501 | 87,344 | I |
| Prokupets Elena Director | 2021-09-10 | Sale | −1,320 | $50.01 | $66,010 | 591,553 | I |
| Prokupets Elena Director | 2021-09-13 | Sale | −3,330 | $50.07 | $166,730 | 84,014 | I |
| Prokupets Elena Director | 2021-09-13 | Sale | −3,330 | $50.07 | $166,743 | 588,223 | I |
| Open-market sales · 9,210 sh · avg $50.05 · $460,985 | |||||||
Loading xslF345X03/doc4.xml…